Racial Minority Cancer Data: Trends & Disparities in the US
Racial Minority Depiction in US Cancer Data Under Scrutiny
Table of Contents
New Study Highlights Impact of Evolving Race classification Standards on Cancer Statistics
Washington D.C. – A recent study published in CANCER, a peer-reviewed journal of the American Cancer Society, has shed light on how changes in federal race data collection standards have impacted the representation of racial minorities in U.S. cancer statistics. The research,which analyzed cancer incidence and mortality data from the National Cancer Institute’s Surveillance,epidemiology,and end Results Program and the National Vital Statistics System,found significant variations in reported rates for certain groups depending on the classification standards used.
evolving Standards and Their Impact
The study applied race definitions from the U.S. Office of Management and Budget’s (OMB) 1977 and 1997 standards to cancer data. These standards have guided federal data collection,with the 1977 standards defining four primary race categories: White,Black,American Indian or Alaskan Native (AI/AN),and Asian or Pacific Islander (API). The 1997 revision introduced the allowance for reporting multiple races and recommended separating API into Native Hawaiian or Other Pacific Islander (NHOPI) and Asian categories. A 2024 revision is also noted, which added a Middle Eastern/North African category, though the study focused on the earlier standards.
Researchers observed that under the 1997 standards, cancer incidence rates for White and Black populations remained similar to those reported under the 1977 standards. However, a notable finding was the substantially lower incidence rates reported for AI/AN populations when using the 1997 standards compared to the 1977 standards. Mortality rates for White, Black, and AI/AN populations showed little difference between the two sets of standards.
Multiracial Data and NHOPI Group
The study also investigated the effect of including multiracial individuals in cancer data.For most racial groups, the inclusion of multiracial individuals within their primary race category did not substantially alter incidence or mortality rates under the 1997 standards.this suggests that the overall population rates were not significantly skewed by this classification method.
An exception was identified within the Native Hawaiian or Other Pacific Islander (NHOPI) group. When multiracial individuals were included in this category, the reported incidence and mortality rates were lower. This finding underscores the potential for nuanced impacts of evolving classification systems on specific demographic groups.
Importance of Accurate Racial Identification
Mandi Yu, PhD, of the National Cancer Institute and corresponding author of the study, emphasized the critical role of race in understanding cancer. “The concept of race plays a critical role in cancer prevention, as it interacts with social and environmental factors to influence cancer risk, incidence, treatment, and outcomes,” Dr. Yu stated.
She further highlighted the necessity of improving data collection practices. “Enhancing the accuracy of patients’ self-reported racial identification and incorporating multiracial classifications into hospital data collection systems are essential steps for improving the comparability between cancer incidence and census-based population data,” Dr. Yu added.
The study’s findings are crucial for public health initiatives aimed at reducing cancer disparities and ensuring equitable access to prevention, diagnosis, and treatment for all populations. accurate and thorough data collection is fundamental to identifying and addressing the unique challenges faced by diverse racial and ethnic groups in the fight against cancer.
**
This details is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article is available via the CANCER Newsroom.*